Key result
Pretreatment with aminoguanidine mitigated doxorubicin-induced increases in serum creatinine, BUN, and inflammatory markers, and reduced structural kidney damage in rats.
Why the study?
Does aminoguanidine prevent doxorubicin-induced nephrotoxicity in male Wistar rats?
Does aminoguanidine prevent doxorubicin-induced nephrotoxicity in male Wistar rats?
Aminoguanidine demonstrates a protective effect against doxorubicin-induced nephrotoxicity in a rat model by modulating reactive oxygen species and cytokines.
Requires human trials before any clinical consideration; leaves open translation of rat renoprotection signals.
Reactive oxygen species and cytokines have been implicated in the nephrotoxicity induced by doxorubicin. The goal of the present study was to determine protective effect of aminoguanidine on doxorubicin-induced nephrotoxicity in rats. Different groups of male Wistar rats received doxorubicin (67.75 mg/kg/i.p./2 days), aminoguanidine alone and aminoguanidine (200 and 400 mg/kg/i.p./30 days) prior to doxorubicin, respectively. Doxorubicin significantly increased serum creatinine (505%), blood urea nitrogen (333%), nitric oxide (406%), and plasma tumor necrosis factor-alpha (706%) as well as urinary albumin (452%) and N-acetyl-β-D-glucosaminidase (415%) compared to control. Moreover, renal glutathione (334%), superoxide dismutase (283%), and catalase (513%) were significantly reduced accompanied with elevation in renal malondialdehyde compared to control. Pretreatment with aminoguanidine mitigated such changes in all mentioned parameters. Histopathological changes showed that doxorubicin-caused significant structural damages to kidneys that were reduced with aminoguanidine. Results indicate that reactive oxygen species and cytokines are involved in doxorubicin-induced nephrotoxicity, which can be reduced by aminoguanidine.
No takes yet. Share an insight, caveat, or question.
Osama M. Abo‐Salem (2012) studied Doxorubicin-induced nephropathy. Aminoguanidine vs. Doxorubicin alone was evaluated on Nephrotoxicity markers (serum creatinine, BUN, NO, TNF-alpha, urinary albumin, NAG, glutathione, SOD, catalase, MDA). Pretreatment with aminoguanidine mitigated doxorubicin-induced increases in serum creatinine, BUN, and inflammatory markers, and reduced structural kidney damage in rats.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: